Verastem Inc (NASDAQ:VSTM)

4.15
Delayed Data
As of 4:00pm ET
 +0.01 / +0.24%
Today’s Change
1.71
Today|||52-Week Range
5.71
+35.18%
Year-to-Date
Verastem (VSTM) in Focus: Stock Moves 8% Higher
Apr 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close4.14
Today’s open4.14
Day’s range4.10 - 4.22
Volume608,156
Average volume (3 months)989,231
Market cap$148.3M
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)+38.51%
Earnings growth (this year)-75.61%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.77

Competitors

 Today’s
change
Today’s
% change
VBIVVBI Vaccines Inc-0.14-4.06%
VBLTVascular Biogenics L...-0.02-1.12%
GNCAGenocea Biosciences ...-0.03-3.06%
CBMGCellular Biomedicine...0.000.00%
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$0.00
Annual profit (last year)-$36.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert M. Forrester
Chief Operating Officer
Dan Paterson
Corporate headquarters
Needham, Massachusetts

Forecasts